Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Surg Oncol. 2001 Jun;27(4):409-13.

Incidence and clinical course of de-novo malignancies in renal allograft recipients.

Author information

  • 1Department of Surgery, University Medical Centre St Radboud, Nijmegen, The Netherlands. t.winkelhorst@heel.azn.nl

Abstract

BACKGROUND:

This study was designed to evaluate the development of malignancies after renal transplantation in a single centre. The outcome was studied in patients developing a malignant neoplasm after renal transplantation.

METHODS:

Malignancies are registered in a database containing relevant data about the patients with a renal transplant. This database and the files of the patients developing a malignant neoplasm, have been studied as to stage at presentation, therapy and outcome.

RESULTS:

In 1546 patients with 2075 renal transplantations, 240 malignancies developed in 231 recipients. Skin cancers often present with more than one lesion of the same histological type. After the first skin tumour, about half of the patients developed more lesions, of the same or a different histological type. The prognosis of skin tumours is relatively good, but most malignancies in all other categories have a poor prognosis.

CONCLUSIONS:

Cutaneous neoplasms tend to be multiple, but can be controlled by regular examination of the skin. Most malignant lymphomas do develop outside the lymphoproliferative system and have a poor prognosis. Patients with a solid tumour of the other tracts often present in an advanced stage of disease, which makes the outcome of treatment, if possible at all, disappointing.

Copyright Harcourt Publishers Limited.

PMID:
11417989
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk